SCHEMBL25878289

SCHEMBL25878289

CC(C)(C)c1cc(F)c2cc(C3CCCCC3)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
BACE1 P56817 1/20 0.38
HTR1D P28221 2/20 0.36
EGLN1 Q9GZT9 3/20 0.35
EPHX2 P34913 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
PDK2 Q15119 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
APP P05067 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25888198 0.77 APP (0.43) CYP3A4CYP2C9BACE1HTR1DHRH3
SCHEMBL20043182 0.74 KCNH2 (0.42) HTR1DMEN1KMT2ATDP1ALDH1A1
SCHEMBL20047550 0.71 AKR1C3 (0.35) HTR1DLMNA
SCHEMBL6902989 0.70 SLC6A2 (0.49) CYP3A4CYP2C9EPHX2ALDH1A1LMNA
SCHEMBL4329015 0.70 SLC6A2 (0.49) CYP3A4CYP2C9EPHX2ALDH1A1LMNA
SCHEMBL18210664 0.70 CYP2C9 (0.38) CYP3A4CYP2C9PDK2APPCYP1A2
SCHEMBL22960056 0.69 BACE1 (0.34) CYP3A4CYP2C9BACE1HTR1DEPHX2
SCHEMBL26566969 0.69 ALDH1A1 (0.41) TLR7TDP1ALDH1A1CYP1A2CYP2D6
SCHEMBL5146562 0.69 SLC6A2 (0.46) CYP3A4CYP2C9EPHX2ALDH1A1LMNA
SCHEMBL2874346 0.68 KMO (0.49) PDK2CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192668-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192668-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM CYP3A4 1204/4885CYP2C9 1549/4885BACE1 157/4885
US-20230192668-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF XPO4, OR10J3, EPB41 CYP3A4 258/4885CYP2C9 222/4885BACE1 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.